US Medical and Diagnostic Laboratory Services Market to Grow with a CAGR of 8.75% through 2030

Rising Burden of Chronic and Lifestyle-Related Diseases and Advancement in Diagnostic Technologies are expected to drive the US Medical and Diagnostic Laboratory Services Market growth in the forecast period, 2026-2030

According to TechSci Research report, “US Medical and Diagnostic Laboratory Services Market – By Region, Competition, Forecast & Opportunities, 2030F”, the US Medical and Diagnostic Laboratory Services Market stood at USD 75.25 Billion in 2024 and is anticipated to grow with a CAGR of 8.75% in the forecast period, 2026-2030.

The U.S. healthcare model is evolving from episodic, treatment-centered care to proactive, prevention-focused strategies placing diagnostic testing at the core of population health management. Corporations and payers are scaling investments in regular health assessments including biometric screenings, metabolic panels, and cardiovascular risk profiling to identify high-risk individuals early and contain long-term healthcare costs. Increased health consciousness and digital access to healthcare services have accelerated demand for diagnostics beyond traditional clinical referrals. Tests related to hormone balance, allergies, fertility, gut health, and food sensitivity are now being accessed directly by consumers, creating new, decentralized revenue channels. Under models like Accountable Care Organizations (ACOs) and bundled payments, providers are rewarded for preventing complications and hospital admissions. As a result, diagnostic labs play a more strategic role in early detection, risk stratification, and longitudinal patient monitoring, which is essential for meeting performance benchmarks and quality outcomes. This fundamental realignment is redefining diagnostics as a proactive enabler of cost-efficient, outcome-oriented care.

The widespread adoption of digital health solutions, catalyzed by the COVID-19 pandemic, has expanded the diagnostic footprint across new access points and consumer journeys. Virtual consultations now routinely include lab orders, digital prescriptions, and real-time delivery of diagnostic results, enabling a more connected and frictionless care experience. This integration strengthens the position of labs within emerging digital health ecosystems. Patients increasingly prefer the convenience of ordering tests online, utilizing home sample collection kits, and viewing results via secure mobile apps. This model fosters transparency, autonomy, and test volume growth outside of brick-and-mortar clinical settings. Diagnostic labs are evolving into health intelligence hubs, leveraging real-time dashboards, AI-driven interpretations, and EHR interoperability to deliver actionable clinical insights. This positions labs as data infrastructure partners to physicians, payers, and digital health platforms. The digital transformation of diagnostics is not only enhancing operational efficiency but also expanding market reach to tech-enabled and time-sensitive consumers.

Government entities continue to recognize diagnostics as a cornerstone of national healthcare preparedness and chronic disease management, translating into strong institutional backing. In the post-pandemic era, federal and state agencies were investing in enhanced laboratory capacity to support early outbreak detection, antimicrobial resistance tracking, and biosurveillance systems thereby anchoring diagnostics in public health infrastructure. The expansion of test reimbursements by Medicare, Medicaid, and commercial insurers for preventive services such as cancer screening, cardiovascular risk assessment, and chronic disease biomarkers is driving higher testing uptake across age groups. Strategic funding initiatives and public-private partnerships are supporting lab modernization, genomic research programs, and innovations in decentralized testing technologies, from mobile units to rural diagnostic access. This policy environment provides both financial stimulus and long-term clarity, encouraging sustained investment and innovation in the diagnostic space.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "US Medical and Diagnostic Laboratory Services Market”

The US Medical and Diagnostic Laboratory Services Market is segmented into test, product, end user, regional distribution, and company.

Based on its end user, the Diagnostic Laboratory segment has emerged as the predominant market leader, Diagnostic laboratories such as Quest Diagnostics, Labcorp, and Sonic Healthcare USA operate on a large, often national scale, allowing them to process millions of specimens daily. Their infrastructure supports: High-volume routine testing (e.g., blood chemistry, hematology, urinalysis), Specialized and esoteric testing (e.g., genomics, toxicology, infectious disease panels), Automation and centralized processing, resulting in faster turnaround times and lower per-test costs.

These labs serve a wide range of clients including physician offices, retail clinics, employers, nursing homes, insurers, and telehealth providers beyond what hospital-based labs or point-of-care settings typically handle. Their extended footprint enables: Direct-to-consumer services, Home sample collection, Integration with digital health platforms and EHR systems. Diagnostic labs have established broad insurance contracts with Medicare, Medicaid, and private payers, ensuring high patient access and consistent reimbursement. Their strong payer relationships help them maintain high volumes and repeat test utilization.

Major companies operating in US Medical and Diagnostic Laboratory Services Market are:

• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc.
• BIOMÉRIEUX
• Siemens Medical Solutions USA, Inc.
• Laboratory Corporation of America® Holdings
• Sonic Healthcare USA
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories
• Danaher Corp.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The U.S. Medical and Diagnostic Laboratory Services market is evolving into a strategic pillar of modern healthcare driven by technological innovation, rising demand for preventive diagnostics, and the expansion of digital health ecosystems. As the industry continues to shift from volume-based to value-driven care, diagnostic laboratories are positioned at the forefront of early intervention, population health management, and data-informed clinical decision-making. With strong institutional support, growing consumer engagement, and increasing test complexity, the sector is poised for sustained growth, playing a critical role in shaping the future of cost-efficient and outcome-focused healthcare delivery in the United States.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“US Medical and Diagnostic Laboratory Services Market, By Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Other), By Product (Instruments, Reagents, Other), By End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of US Medical and Diagnostic Laboratory Services Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in US Medical and Diagnostic Laboratory Services Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]